🇺🇸 FDA
Patent

US 6440960

CRF receptor antagonists and methods relating thereto

expired A61PA61P25/00A61P25/22

Quick answer

US patent 6440960 (CRF receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P25/00, A61P25/22, A61P25/24, A61P43/00